Home Data Calendar Blog

AMRX

Tables

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Weighted Average Number Of Diluted Shares Outstanding		307.28	NA	159.69	154.89	152.11	NA	151.39	150.99	149.89	NA	149.29	151.99	151.22	NA	147.56	147.39	147.96	NA	130.73	128.02	127.69	NA	128.22	NA	NA	NA	NA	NA	NA
Weighted Average Number Of Shares Outstanding Basic		307.28	NA	154.22	153.74	152.11	NA	151.39	150.99	149.89	NA	149.29	149.00	148.01	NA	147.56	147.39	147.18	NA	130.73	128.02	127.69	NA	127.25	NA	NA	NA	NA	NA	NA
Earnings Per Share Basic		-0.30	-0.58	0.06	0.08	-0.05	-0.03	-0.02	-0.80	-0.01	-0.04	-0.03	0.10	0.05	-0.02	-0.06	-0.08	0.78	-0.23	-2.03	-0.13	-0.37	-0.07	0.05	-0.15	0.00	0.00	0.00	0.00	0.00
Earnings Per Share Diluted		-0.30	-0.57	0.06	0.08	-0.05	-0.03	-0.02	-0.80	-0.01	-0.04	-0.03	0.10	0.04	-0.02	-0.06	-0.08	0.78	-0.23	-2.03	-0.13	-0.37	-0.07	0.05	-0.15	0.00	0.00	0.00	0.00	0.00

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenue From Contract With Customer Excluding Assessed Tax		659.19	616.98	620.04	599.05	557.54	609.76	545.56	559.36	497.63	536.90	528.59	535.08	493.11	510.03	519.29	464.66	498.53	397.33	378.28	404.64	446.12	497.53	476.49	413.79	275.19	293.37	254.73	259.87	225.68
Revenues		659.19	616.98	620.04	599.05	557.54	609.76	545.56	559.36	497.63	536.90	528.59	535.08	493.11	510.03	519.29	464.66	498.53	397.33	378.28	404.64	446.12	497.53	476.49	413.79	275.19	293.37	254.73	259.87	225.68
Cost Of Goods And Services Sold		421.13	427.15	387.51	379.02	379.35	389.05	350.65	353.72	323.06	348.49	329.39	322.58	301.54	342.96	353.35	319.67	313.58	273.37	267.72	296.38	309.74	304.12	276.38	235.49	130.59	141.95	119.72	136.14	NA
Gross Profit		238.06	189.83	232.53	220.02	178.19	215.39	194.23	200.52	174.57	166.40	198.51	212.50	191.56	167.07	133.59	144.24	183.50	110.23	54.43	105.25	83.08	193.41	200.10	178.29	144.59	151.42	135.01	123.73	116.02
Research And Development Expense		39.30	46.09	41.38	37.80	38.69	41.91	50.23	50.75	52.80	51.87	48.93	52.86	48.18	53.46	44.52	45.57	36.38	48.05	38.12	48.02	53.86	56.65	43.00	50.34	44.21	43.49	41.32	47.18	NA
Selling General And Administrative Expense		112.59	109.00	113.01	105.57	102.10	102.16	100.07	98.81	98.67	97.22	91.40	86.16	90.73	84.69	83.12	80.94	77.98	74.08	63.80	67.28	84.44	74.24	78.08	53.00	25.12	26.97	27.44	26.94	NA
Operating Income Loss		-10.75	14.19	75.65	80.08	34.45	36.03	44.35	-198.62	23.30	11.18	28.52	67.12	45.91	20.18	2.44	10.75	57.79	-23.14	-112.27	-18.91	-94.36	23.28	74.56	-181.06	63.55	79.02	78.75	44.60	NA
Interest Paid Net		64.51	56.21	47.90	47.64	41.07	50.51	34.89	30.03	27.29	30.07	30.24	31.52	29.92	30.98	30.77	33.05	35.39	36.70	40.77	41.07	40.03	42.43	38.68	31.55	18.84	17.12	17.68	NA	NA
Interest Income Expense Nonoperating Net		-65.70	-59.55	-50.91	-50.86	-49.31	-47.03	-42.39	-35.62	-33.34	-33.96	-34.40	-34.08	-33.88	-34.53	-34.90	-36.67	-39.90	-38.83	-42.21	-43.89	-43.28	-42.88	-43.02	-36.62	-21.05	-19.96	-19.22	-17.73	NA
Income Tax Expense Benefit		6.16	9.88	-2.08	-0.02	0.67	-1.80	4.57	7.35	-3.46	4.14	4.05	2.65	0.36	1.49	0.14	2.19	-108.17	7.79	389.67	-5.70	-8.43	5.52	5.11	-12.42	0.36	-0.12	-0.74	1.90	NA
Income Taxes Paid Net		-4.57	-2.92	-3.49	0.50	3.42	-22.59	16.69	-11.13	4.39	-3.98	-16.19	3.88	0.73	-9.30	113.96	-1.09	-3.43	-1.60	3.32	-1.18	9.71	29.57	5.38	1.51	-1.51	1.76	4.02	NA	NA
Profit Loss		-81.68	-93.34	25.03	29.68	-10.09	-5.86	-2.39	-240.08	-6.46	-20.46	-6.09	32.18	14.54	-6.96	-22.03	-23.94	121.52	-64.90	-363.39	-50.53	-124.75	-20.33	17.46	-250.09	51.65	62.19	27.12	37.75	42.26
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax		15.54	-37.25	-5.29	8.31	-14.27	-3.27	32.64	14.07	53.62	18.24	2.71	0.70	20.77	3.75	-1.60	-9.77	-62.66	NA	NA	0.00	0.00	NA	NA	NA	NA	NA	NA	NA	NA
Net Income Loss		-91.64	-101.41	15.54	22.23	-15.63	-12.03	-7.61	-242.13	-8.82	-21.80	-7.78	29.99	12.75	-3.04	-8.97	-12.00	115.07	-32.13	-265.01	-16.90	-47.88	-8.77	6.89	-17.86	NA	0.00	0.00	0.00	NA
Comprehensive Income Net Of Tax		-83.00	-135.55	5.46	16.23	-13.18	-6.93	8.98	-119.59	22.43	2.03	-3.47	14.97	13.81	-3.04	-10.57	-18.27	81.73	-26.85	-262.82	-19.55	-44.20	-6.63	3.57	-20.27	0.00	0.00	0.00	0.00	NA
Net Income Loss Available To Common Stockholders Basic		-91.64	-98.65	9.68	11.92	-6.94	-4.33	-2.69	-120.81	-2.16	-6.38	-4.24	14.53	6.71	-3.04	-8.97	-12.00	115.07	-32.13	-265.01	-16.90	-47.88	-8.77	6.95	-19.10	0.00	0.00	0.00	0.00	0.00

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets		3456.40	3472.57	3687.08	3700.89	3626.61	3799.34	3874.04	4041.41	3888.97	3939.66	3974.41	4023.05	3960.07	4006.03	4037.54	4056.76	4390.80	3665.89	3703.94	4262.14	4384.59	4352.74	4582.05	4544.59	0.00	0.00	NA	NA	NA
Liabilities And Stockholders Equity		3456.40	3472.57	3687.08	3700.89	3626.61	3799.34	3874.04	4041.41	3888.97	3939.66	3974.41	4023.05	3960.07	4006.03	4037.54	4056.76	4390.80	3665.89	3703.94	4262.14	4384.59	4352.74	4582.05	4544.59	0.00	0.00	NA	NA	NA
Stockholders Equity		-63.72	19.78	330.86	318.17	294.41	298.42	297.47	280.33	391.12	360.34	350.51	346.11	323.01	303.27	301.04	306.00	318.38	232.01	218.00	459.66	472.20	504.75	NA	NA	0.00	0.00	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Assets Current		1380.04	1377.86	1456.08	1421.79	1307.33	1411.82	1419.83	1553.60	1389.68	1520.11	1570.34	1563.47	1559.66	1551.54	1543.72	1480.87	1773.70	1210.21	1205.83	1185.85	1267.97	1286.64	1431.30	1347.89	0.00	0.00	NA	NA	NA
Cash And Cash Equivalents At Carrying Value		46.52	91.54	86.93	109.28	144.67	25.98	87.33	91.98	210.48	247.79	302.65	278.31	452.10	341.38	281.28	266.14	405.24	151.20	212.74	54.89	63.95	213.39	165.19	61.52	0.00	0.00	19.35	48.22	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		51.62	99.11	95.61	114.58	151.07	35.23	95.89	98.18	216.54	256.74	310.62	283.15	455.81	347.12	283.65	268.27	406.93	152.82	217.06	57.02	66.74	218.78	172.19	68.59	52.62	77.92	21.35	51.84	NA
Inventory Net		570.65	581.38	576.47	550.56	529.04	530.74	543.86	533.03	512.24	489.39	520.25	523.38	497.01	490.65	475.76	443.96	437.96	381.07	401.83	414.63	448.29	457.22	490.77	512.48	NA	284.04	NA	NA	NA
Prepaid Expense And Other Assets Current		87.30	82.69	91.44	81.76	81.42	103.56	149.65	232.20	121.41	110.22	110.21	103.80	75.14	73.47	76.26	184.75	204.41	70.16	66.70	77.06	111.56	128.32	126.39	139.60	NA	42.40	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Property Plant And Equipment Gross		NA	955.60	NA	NA	NA	915.79	NA	NA	NA	908.72	NA	NA	NA	809.89	NA	NA	NA	754.04	NA	NA	NA	753.58	760.57	748.79	NA	643.13	NA	NA	NA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment		NA	508.03	NA	NA	NA	445.97	NA	NA	NA	394.56	NA	NA	NA	332.14	NA	NA	NA	276.05	NA	NA	NA	209.44	193.07	179.46	NA	156.37	NA	NA	NA
Amortization Of Intangible Assets		39.90	40.70	40.60	40.80	41.10	44.62	44.55	41.98	40.92	43.70	43.81	43.52	41.67	43.87	44.55	43.98	42.58	40.18	38.02	34.80	30.96	28.88	25.66	16.69	1.76	0.92	1.28	0.89	NA
Property Plant And Equipment Net		439.81	447.57	451.85	459.11	462.61	469.81	470.15	483.62	500.91	514.16	459.65	468.42	471.17	477.75	462.44	460.53	467.56	478.00	490.71	508.09	514.41	544.15	567.50	569.33	NA	486.76	NA	NA	NA
Goodwill		598.55	598.63	598.63	599.21	599.16	598.85	599.50	600.97	602.89	593.02	566.41	549.09	522.76	522.81	522.69	527.48	514.73	419.50	419.67	420.02	421.64	426.23	410.62	386.48	NA	26.44	NA	NA	NA
Indefinite Lived Intangible Assets Excluding Goodwill		355.85	355.85	387.86	390.36	390.36	390.75	405.43	405.43	405.43	405.43	405.52	422.99	379.39	379.39	381.12	381.12	381.12	382.07	382.52	428.78	429.14	451.93	565.87	571.25	NA	1.15	NA	NA	NA
Intangible Assets Net Excluding Goodwill		859.27	890.42	982.53	1015.38	1055.32	1096.09	1159.01	1204.22	1209.82	1166.92	1232.73	1293.33	1262.95	1304.63	1349.11	1423.83	1475.16	1382.75	1435.80	1553.33	1591.16	1654.97	1733.02	1788.53	NA	44.60	NA	NA	NA
Finite Lived Intangible Assets Net		503.43	534.58	594.68	625.02	664.96	705.34	753.58	798.80	804.39	761.50	827.20	870.34	883.56	925.23	968.00	1042.71	1094.05	1000.68	1053.28	1124.55	1162.02	1203.04	1167.15	1217.28	NA	43.45	NA	NA	NA
Other Assets Noncurrent		73.75	55.52	89.04	93.24	86.43	103.22	108.26	79.84	63.94	20.61	19.53	19.22	19.56	31.89	31.14	28.73	26.46	44.27	18.61	63.46	62.42	67.59	73.64	78.65	NA	11.26	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Liabilities Current		834.39	846.60	760.60	777.35	703.71	752.80	818.00	993.06	602.04	677.24	667.34	672.86	636.78	676.90	667.89	655.02	965.07	550.41	534.91	546.16	599.53	553.85	749.27	669.74	0.00	0.00	NA	NA	NA
Long Term Debt Current		33.66	34.12	30.53	30.41	29.96	29.96	29.94	29.92	30.52	30.61	30.47	30.46	29.82	44.23	29.78	29.76	29.74	21.48	NA	NA	NA	21.45	NA	NA	NA	89.17	NA	NA	NA
Accounts Payable Current		175.32	143.57	177.40	139.53	136.92	165.98	NA	NA	NA	131.08	NA	NA	NA	153.14	NA	NA	NA	103.02	NA	NA	NA	114.85	124.54	169.05	NA	70.01	NA	NA	NA
Other Accrued Liabilities Current		59.97	48.22	55.45	44.47	44.45	45.81	NA	NA	NA	40.88	NA	NA	NA	46.93	NA	NA	NA	35.90	NA	NA	NA	37.35	30.50	35.18	NA	23.82	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Liabilities Noncurrent		2638.62	2564.67	2735.10	2740.66	2760.70	2837.61	2839.38	2857.47	2863.10	2878.54	2908.65	2945.81	2943.50	2972.39	3009.52	3018.34	3009.71	2768.70	2773.31	2966.63	2985.28	2902.52	2917.46	2923.51	NA	1420.59	NA	NA	NA
Long Term Debt		2411.37	2420.13	2572.35	2579.58	2591.69	2621.94	2637.16	2652.37	NA	2710.67	NA	NA	NA	2779.49	2786.91	2794.33	2801.76	2630.53	NA	NA	NA	2652.05	NA	2662.73	NA	1444.44	NA	NA	NA
Long Term Debt Noncurrent		2377.71	2386.00	2541.81	2549.18	2561.72	2591.98	2607.22	2622.45	2672.66	2680.05	2687.67	2720.12	2728.21	2735.26	2757.14	2764.58	2772.03	2609.05	2614.41	2619.79	2625.15	2630.60	NA	2641.30	NA	1355.27	NA	NA	NA
Minority Interest		0.10	0.23	-176.62	-167.40	-159.75	-114.44	-103.18	-107.34	16.28	6.63	32.66	44.16	43.69	41.66	47.16	65.02	85.08	114.78	177.72	289.70	327.58	391.61	NA	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Stockholders Equity		-63.72	19.78	330.86	318.17	294.41	298.42	297.47	280.33	391.12	360.34	350.51	346.11	323.01	303.27	301.04	306.00	318.38	232.01	218.00	459.66	472.20	504.75	NA	NA	0.00	0.00	NA	NA	NA
Stockholders Equity Including Portion Attributable To Noncontrolling Interest		-63.63	20.01	154.24	150.77	134.67	183.98	194.29	172.99	407.41	366.97	383.17	390.27	366.71	344.93	348.20	371.02	403.46	346.79	395.72	749.35	799.78	896.36	915.32	939.49	NA	0.00	NA	NA	NA
Additional Paid In Capital		538.72	539.24	715.45	708.23	700.72	691.63	683.75	675.59	666.80	658.35	650.54	642.66	634.48	628.41	623.13	617.50	611.60	606.97	565.64	544.16	537.16	530.44	520.16	517.12	NA	8.56	NA	NA	NA
Retained Earnings Accumulated Deficit		-581.82	-490.18	-391.53	-401.21	-413.13	-406.18	-401.85	-399.16	-278.35	-276.20	-269.82	-265.58	-280.12	-286.82	-283.78	-274.81	-262.81	-377.88	-345.75	-80.75	-63.84	-20.92	-12.15	-19.10	NA	-382.79	NA	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		-23.71	-32.35	3.87	8.08	3.76	9.94	12.54	0.87	-0.35	-24.83	-33.23	-33.98	-34.36	-41.32	-41.31	-39.70	-33.41	-0.07	-4.88	-6.75	-4.10	-7.75	-9.89	-6.50	NA	-14.23	NA	NA	NA
Minority Interest		0.10	0.23	-176.62	-167.40	-159.75	-114.44	-103.18	-107.34	16.28	6.63	32.66	44.16	43.69	41.66	47.16	65.02	85.08	114.78	177.72	289.70	327.58	391.61	NA	NA	NA	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		6.72	5.97	6.69	6.56	7.60	7.83	7.69	8.26	8.06	7.74	7.71	7.63	5.33	5.13	5.42	5.66	4.54	5.01	6.09	6.22	4.35	3.61	3.59	1.64	NA	NA	NA	NA	NA
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders		NA	-1.95	10.64	21.20	26.81	0.80	2.50	2.90	4.40	19.00	9.00	17.00	9.00	2.00	0.00	1.00	0.00	-0.10	0.10	0.00	0.00	13.50	35.50	NA	NA	NA	NA	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-4.41	135.82	81.39	-11.35	139.71	-23.29	93.57	-125.52	120.34	63.26	82.36	-51.93	148.13	105.96	44.78	179.24	49.03	-50.89	139.91	21.09	-108.41	259.65	62.13	-98.58	27.03	65.27	73.51	NA	NA
Net Cash Provided By Used In Investing Activities		-19.76	-31.69	-13.48	-12.28	-11.74	-11.47	-49.33	-16.12	-97.39	-86.97	-11.63	-82.89	-12.69	-31.80	-14.78	-8.93	-262.04	-4.77	29.98	-23.33	-21.47	5.32	-40.77	-341.43	-19.50	-8.90	-35.04	NA	NA
Net Cash Provided By Used In Financing Activities		-23.16	-100.83	-86.58	-12.26	-12.90	-22.17	-46.13	23.25	-61.57	-30.35	-43.55	-38.07	-26.15	-11.28	-14.81	-310.08	467.98	-7.30	-7.60	-9.07	-21.86	-218.92	82.60	457.24	-33.25	0.50	-63.77	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Operating Activities		-4.41	135.82	81.39	-11.35	139.71	-23.29	93.57	-125.52	120.34	63.26	82.36	-51.93	148.13	105.96	44.78	179.24	49.03	-50.89	139.91	21.09	-108.41	259.65	62.13	-98.58	27.03	65.27	73.51	NA	NA
Net Income Loss		-91.64	-101.41	15.54	22.23	-15.63	-12.03	-7.61	-242.13	-8.82	-21.80	-7.78	29.99	12.75	-3.04	-8.97	-12.00	115.07	-32.13	-265.01	-16.90	-47.88	-8.77	6.89	-17.86	NA	0.00	0.00	0.00	NA
Profit Loss		-81.68	-93.34	25.03	29.68	-10.09	-5.86	-2.39	-240.08	-6.46	-20.46	-6.09	32.18	14.54	-6.96	-22.03	-23.94	121.52	-64.90	-363.39	-50.53	-124.75	-20.33	17.46	-250.09	51.65	62.19	27.12	37.75	42.26
Increase Decrease In Accounts Receivable		55.17	-77.23	17.92	128.99	-195.97	113.29	-60.13	150.83	-124.27	34.52	-24.06	121.55	-108.39	-67.53	126.52	-136.66	60.89	86.27	-116.50	-2.06	165.01	-163.79	14.66	65.03	-4.98	13.21	-20.40	NA	NA
Increase Decrease In Inventories		12.20	23.09	42.57	38.02	22.51	11.07	25.93	39.85	25.55	-16.63	11.06	34.30	20.28	33.06	47.54	30.40	2.78	-5.51	6.25	5.48	14.18	-10.83	-17.95	24.07	47.59	6.64	14.30	NA	NA
Share Based Compensation		6.72	5.97	6.69	6.56	7.60	7.83	7.69	8.26	8.06	7.74	7.71	7.63	5.33	5.13	5.42	5.66	4.54	5.01	6.09	6.22	4.35	3.61	3.59	160.40	0.00	0.00	0.00	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Investing Activities		-19.76	-31.69	-13.48	-12.28	-11.74	-11.47	-49.33	-16.12	-97.39	-86.97	-11.63	-82.89	-12.69	-31.80	-14.78	-8.93	-262.04	-4.77	29.98	-23.33	-21.47	5.32	-40.77	-341.43	-19.50	-8.90	-35.04	NA	NA
Payments To Acquire Property Plant And Equipment		9.20	9.87	11.66	12.00	9.69	11.47	19.10	5.05	10.79	17.50	10.64	7.81	11.78	29.53	10.99	8.55	7.37	4.52	13.04	11.64	17.99	20.02	26.46	17.10	19.50	24.62	15.54	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Net Cash Provided By Used In Financing Activities		-23.16	-100.83	-86.58	-12.26	-12.90	-22.17	-46.13	23.25	-61.57	-30.35	-43.55	-38.07	-26.15	-11.28	-14.81	-310.08	467.98	-7.30	-7.60	-9.07	-21.86	-218.92	82.60	457.24	-33.25	0.50	-63.77	NA	NA

		2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31
Revenues		659.19	616.98	620.04	599.05	557.54	609.76	545.56	559.36	497.63	536.90	528.59	535.08	493.11	510.03	519.29	464.66	498.53	397.33	378.28	404.64	446.12	497.53	476.49	413.79	275.19	293.37	254.73	259.87	225.68
Operating, Amneal Specialty Pharma		105.23	NA	97.30	96.99	91.68	102.55	89.48	97.00	85.09	101.01	92.75	88.64	95.93	85.47	87.87	94.26	87.98	97.05	87.26	69.58	63.64	86.63	85.31	52.02	0.00	NA	0.00	NA	NA
Operating, Av K A R E		162.66	149.46	131.88	128.35	122.06	108.04	105.81	97.46	94.80	89.62	88.72	86.00	84.67	82.42	89.51	63.85	57.97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating, Generics		391.29	363.04	390.86	373.70	343.81	399.17	350.27	364.89	317.75	346.27	347.13	360.44	312.51	342.14	341.92	306.56	352.59	300.28	291.02	335.06	382.48	410.90	391.18	361.77	275.19	NA	NA	NA	NA
Anti Infective,US, Generics		6.11	7.24	7.38	6.09	5.17	6.42	4.96	5.57	6.25	5.50	9.41	9.68	5.91	7.79	9.81	9.72	13.25	12.32	9.91	8.15	5.94	NA	NA	NA	NA	NA	NA	NA	NA
Antiviral,US, Generics		3.87	3.69	7.15	3.60	25.47	22.95	5.78	1.30	10.57	3.27	9.76	-0.26	-7.94	-0.29	9.24	0.95	15.82	8.11	3.57	1.35	14.46	NA	NA	NA	NA	NA	NA	NA	NA
Cardiovascular System,US, Generics		45.88	41.83	32.46	33.15	32.50	33.76	28.93	32.04	23.45	34.73	35.69	36.13	35.31	31.35	28.52	25.11	29.68	23.47	26.24	31.14	36.22	NA	NA	NA	NA	NA	NA	NA	NA
Central Nervous System,US, Generics		109.46	104.43	96.59	83.60	84.58	106.49	96.88	108.79	81.12	86.93	91.26	106.63	96.29	119.46	107.14	96.23	101.58	87.42	93.82	117.40	124.78	NA	NA	NA	NA	NA	NA	NA	NA
Central Nervous System,US, Specialty		66.28	69.14	61.14	59.56	60.14	70.35	61.78	65.36	58.17	75.49	68.87	65.13	67.71	75.31	68.06	74.06	68.31	74.81	67.45	50.69	42.90	NA	NA	NA	NA	NA	NA	NA	NA
Dermatology,US, Generics		18.98	17.64	17.28	17.95	18.00	17.81	17.33	17.94	13.48	12.92	14.86	14.82	12.88	15.77	14.82	10.44	15.24	16.68	15.77	14.77	12.97	NA	NA	NA	NA	NA	NA	NA	NA
Gastroenterology,US, Generics		18.20	14.39	18.86	19.91	14.36	19.52	17.13	17.53	16.62	20.16	17.17	19.70	19.46	18.92	21.37	16.62	23.54	14.21	9.08	9.94	9.56	NA	NA	NA	NA	NA	NA	NA	NA
Government Label,US, Av K A R E		34.95	34.68	32.76	29.87	24.52	25.50	26.00	22.28	24.46	28.24	29.90	29.17	31.07	28.70	28.90	25.07	21.38	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Hormonal Allergy,US, Generics		107.71	94.03	126.42	126.44	104.85	110.51	119.73	118.31	96.37	101.11	107.61	111.65	106.70	84.08	93.58	89.28	87.48	84.39	85.25	92.29	102.72	NA	NA	NA	NA	NA	NA	NA	NA
Hormonal Allergy,US, Specialty		29.38	28.22	28.49	29.01	24.76	25.71	22.01	24.32	19.42	19.17	16.42	16.01	16.80	13.97	13.04	13.67	13.95	13.24	11.52	9.89	10.90	NA	NA	NA	NA	NA	NA	NA	NA
Institutional,US, Av K A R E		10.86	9.62	10.55	8.98	8.86	7.07	8.30	6.06	6.32	6.34	7.87	5.78	5.18	5.73	4.89	4.51	3.41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
License Agreement,US, Specialty		4.48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Metabolic Disease Endocrine,US, Generics		11.19	10.67	11.03	14.94	9.27	10.63	9.28	9.99	11.23	12.13	12.89	6.88	6.56	11.61	9.99	6.77	17.23	14.48	12.57	10.89	17.85	NA	NA	NA	NA	NA	NA	NA	NA
Oncology,US, Generics		38.53	33.61	37.72	28.55	10.58	16.41	12.24	18.42	17.21	29.64	21.20	33.45	19.03	15.76	13.93	16.57	15.97	9.74	16.27	21.75	14.96	NA	NA	NA	NA	NA	NA	NA	NA
Other Therapeutic Classes,US, Generics		18.52	24.13	27.27	27.81	25.89	31.78	29.10	22.33	35.36	30.07	18.98	11.14	9.73	28.13	22.66	26.67	21.75	NA	10.13	15.26	18.18	NA	NA	NA	NA	NA	NA	NA	NA
Other Therapeutic Classes,US, Specialty		5.10	7.13	7.67	8.42	6.78	6.49	5.69	6.84	7.43	6.36	7.45	7.49	11.42	-1.71	5.63	5.89	5.39	NA	7.76	8.46	8.82	NA	NA	NA	NA	NA	NA	NA	NA
Respiratory,US, Generics		11.14	10.93	7.83	11.14	12.81	14.58	8.72	12.12	5.67	9.09	8.23	10.46	8.18	9.19	10.88	7.24	10.07	9.51	7.77	8.42	9.22	NA	NA	NA	NA	NA	NA	NA	NA
Distribution Service,US, Av K A R E		109.71	98.48	81.90	83.80	83.23	70.00	66.06	64.24	60.26	51.06	48.05	48.32	45.50	44.85	53.40	31.84	31.59	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product And Service Other,US, Av K A R E		7.14	6.69	6.66	5.70	5.45	5.48	5.45	4.88	3.76	3.98	2.90	2.73	2.92	3.14	2.31	2.42	1.59	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Av K A R E		162.66	149.46	131.88	128.35	122.06	108.04	105.81	97.46	94.80	89.62	88.72	86.00	84.67	82.42	89.51	63.85	57.97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Generics		391.29	363.04	390.86	373.70	343.81	399.17	350.27	364.89	317.75	346.27	347.13	360.44	312.51	342.14	341.92	306.56	352.59	300.28	291.02	335.06	382.48	NA	NA	NA	NA	NA	NA	NA	NA
Specialty		105.23	104.48	97.30	96.99	91.68	102.55	89.48	97.00	85.09	101.01	92.75	88.64	95.93	85.47	87.87	94.26	87.98	97.05	87.26	69.58	63.64	NA	NA	NA	NA	NA	NA	NA	NA
Non Us, Generics		1.72	0.45	0.87	0.55	0.30	0.27	0.20	0.57	0.42	0.71	0.05	0.15	0.40	0.39	0.00	0.96	0.98	0.61	0.64	3.72	15.63	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		659.19	616.98	620.04	599.05	557.54	609.76	545.56	559.36	497.63	536.90	528.59	535.08	493.11	510.03	519.29	464.66	498.53	397.33	378.28	404.64	446.12	497.53	476.49	413.79	275.19	293.37	254.73	259.87	225.68
Operating, Amneal Specialty Pharma		105.23	NA	97.30	96.99	91.68	102.55	89.48	97.00	85.09	101.01	92.75	88.64	95.93	85.47	87.87	94.26	87.98	97.05	87.26	69.58	63.64	86.63	85.31	52.02	0.00	NA	0.00	NA	NA
Operating, Av K A R E		162.66	149.46	131.88	128.35	122.06	108.04	105.81	97.46	94.80	89.62	88.72	86.00	84.67	82.42	89.51	63.85	57.97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Operating, Generics		391.29	363.04	390.86	373.70	343.81	399.17	350.27	364.89	317.75	346.27	347.13	360.44	312.51	342.14	341.92	306.56	352.59	300.28	291.02	335.06	382.48	410.90	391.18	361.77	275.19	NA	NA	NA	NA
Anti Infective,US, Generics		6.11	7.24	7.38	6.09	5.17	6.42	4.96	5.57	6.25	5.50	9.41	9.68	5.91	7.79	9.81	9.72	13.25	12.32	9.91	8.15	5.94	NA	NA	NA	NA	NA	NA	NA	NA
Antiviral,US, Generics		3.87	3.69	7.15	3.60	25.47	22.95	5.78	1.30	10.57	3.27	9.76	-0.26	-7.94	-0.29	9.24	0.95	15.82	8.11	3.57	1.35	14.46	NA	NA	NA	NA	NA	NA	NA	NA
Cardiovascular System,US, Generics		45.88	41.83	32.46	33.15	32.50	33.76	28.93	32.04	23.45	34.73	35.69	36.13	35.31	31.35	28.52	25.11	29.68	23.47	26.24	31.14	36.22	NA	NA	NA	NA	NA	NA	NA	NA
Central Nervous System,US, Generics		109.46	104.43	96.59	83.60	84.58	106.49	96.88	108.79	81.12	86.93	91.26	106.63	96.29	119.46	107.14	96.23	101.58	87.42	93.82	117.40	124.78	NA	NA	NA	NA	NA	NA	NA	NA
Central Nervous System,US, Specialty		66.28	69.14	61.14	59.56	60.14	70.35	61.78	65.36	58.17	75.49	68.87	65.13	67.71	75.31	68.06	74.06	68.31	74.81	67.45	50.69	42.90	NA	NA	NA	NA	NA	NA	NA	NA
Dermatology,US, Generics		18.98	17.64	17.28	17.95	18.00	17.81	17.33	17.94	13.48	12.92	14.86	14.82	12.88	15.77	14.82	10.44	15.24	16.68	15.77	14.77	12.97	NA	NA	NA	NA	NA	NA	NA	NA
Gastroenterology,US, Generics		18.20	14.39	18.86	19.91	14.36	19.52	17.13	17.53	16.62	20.16	17.17	19.70	19.46	18.92	21.37	16.62	23.54	14.21	9.08	9.94	9.56	NA	NA	NA	NA	NA	NA	NA	NA
Government Label,US, Av K A R E		34.95	34.68	32.76	29.87	24.52	25.50	26.00	22.28	24.46	28.24	29.90	29.17	31.07	28.70	28.90	25.07	21.38	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Hormonal Allergy,US, Generics		107.71	94.03	126.42	126.44	104.85	110.51	119.73	118.31	96.37	101.11	107.61	111.65	106.70	84.08	93.58	89.28	87.48	84.39	85.25	92.29	102.72	NA	NA	NA	NA	NA	NA	NA	NA
Hormonal Allergy,US, Specialty		29.38	28.22	28.49	29.01	24.76	25.71	22.01	24.32	19.42	19.17	16.42	16.01	16.80	13.97	13.04	13.67	13.95	13.24	11.52	9.89	10.90	NA	NA	NA	NA	NA	NA	NA	NA
Institutional,US, Av K A R E		10.86	9.62	10.55	8.98	8.86	7.07	8.30	6.06	6.32	6.34	7.87	5.78	5.18	5.73	4.89	4.51	3.41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
License Agreement,US, Specialty		4.48	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Metabolic Disease Endocrine,US, Generics		11.19	10.67	11.03	14.94	9.27	10.63	9.28	9.99	11.23	12.13	12.89	6.88	6.56	11.61	9.99	6.77	17.23	14.48	12.57	10.89	17.85	NA	NA	NA	NA	NA	NA	NA	NA
Oncology,US, Generics		38.53	33.61	37.72	28.55	10.58	16.41	12.24	18.42	17.21	29.64	21.20	33.45	19.03	15.76	13.93	16.57	15.97	9.74	16.27	21.75	14.96	NA	NA	NA	NA	NA	NA	NA	NA
Other Therapeutic Classes,US, Generics		18.52	24.13	27.27	27.81	25.89	31.78	29.10	22.33	35.36	30.07	18.98	11.14	9.73	28.13	22.66	26.67	21.75	NA	10.13	15.26	18.18	NA	NA	NA	NA	NA	NA	NA	NA
Other Therapeutic Classes,US, Specialty		5.10	7.13	7.67	8.42	6.78	6.49	5.69	6.84	7.43	6.36	7.45	7.49	11.42	-1.71	5.63	5.89	5.39	NA	7.76	8.46	8.82	NA	NA	NA	NA	NA	NA	NA	NA
Respiratory,US, Generics		11.14	10.93	7.83	11.14	12.81	14.58	8.72	12.12	5.67	9.09	8.23	10.46	8.18	9.19	10.88	7.24	10.07	9.51	7.77	8.42	9.22	NA	NA	NA	NA	NA	NA	NA	NA
Distribution Service,US, Av K A R E		109.71	98.48	81.90	83.80	83.23	70.00	66.06	64.24	60.26	51.06	48.05	48.32	45.50	44.85	53.40	31.84	31.59	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Product And Service Other,US, Av K A R E		7.14	6.69	6.66	5.70	5.45	5.48	5.45	4.88	3.76	3.98	2.90	2.73	2.92	3.14	2.31	2.42	1.59	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Av K A R E		162.66	149.46	131.88	128.35	122.06	108.04	105.81	97.46	94.80	89.62	88.72	86.00	84.67	82.42	89.51	63.85	57.97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Generics		391.29	363.04	390.86	373.70	343.81	399.17	350.27	364.89	317.75	346.27	347.13	360.44	312.51	342.14	341.92	306.56	352.59	300.28	291.02	335.06	382.48	NA	NA	NA	NA	NA	NA	NA	NA
Specialty		105.23	104.48	97.30	96.99	91.68	102.55	89.48	97.00	85.09	101.01	92.75	88.64	95.93	85.47	87.87	94.26	87.98	97.05	87.26	69.58	63.64	NA	NA	NA	NA	NA	NA	NA	NA
Non Us, Generics		1.72	0.45	0.87	0.55	0.30	0.27	0.20	0.57	0.42	0.71	0.05	0.15	0.40	0.39	0.00	0.96	0.98	0.61	0.64	3.72	15.63	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts